We are live on ! Find out more
CIC

Chase Investment Counsel Portfolio holdings

AUM $474M
1-Year Est. Return 95.11%
This Fund
S&P 500
This Quarter Est. Return
-11.35%
1 Year Est. Return
+95.11%
3 Year Est. Return
+349.64%
5 Year Est. Return
+621.11%
10 Year Est. Return
+3,935.08%
AUM
$185M
AUM Growth
-$43M
Cap. Flow
-$11.3M
Cap. Flow %
-6.09%
Top 10 Hldgs %
33.92%
Holding
128
New
16
Increased
20
Reduced
37
Closed
29

Top Buys

Rank Stock Value
1
USCI icon
US Commodity Index
USCI
+$4.82M
2
SIMO icon
Silicon Motion
SIMO
+$4.05M
3
LPLA icon
LPL Financial
LPLA
+$3.89M
4
WPC icon
W.P. Carey
WPC
+$3.25M
5
ENPH icon
Enphase Energy
ENPH
+$2.99M

Top Sells

Rank Stock Value
1
CNXC icon
Concentrix
CNXC
+$4.16M
2
PCRX icon
Pacira BioSciences
PCRX
+$3.36M
3
CXT icon
Crane NXT
CXT
+$3.32M
4
MS icon
Morgan Stanley
MS
+$2.81M
5
DAR icon
Darling Ingredients
DAR
+$2.77M

Sector Composition

Rank Sector Weight
1 Technology 24.42%
2 Industrials 14.72%
3 Healthcare 12.88%
4 Financials 10.96%
5 Energy 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECK icon
51
Teck Resources
TECK
$32.4B
$1.17M 0.63%
38,414
-25,853
-40% -$1.02M
EWY icon
52
iShares MSCI South Korea ETF
EWY
$25.8B
$1.09M 0.59%
18,690
GLW icon
53
Corning
GLW
$137B
$946K 0.51%
+30,039
New +$1.04M
KT icon
54
KT
KT
$8.81B
$815K 0.44%
58,430
EXPD icon
55
Expeditors International
EXPD
$23.1B
$797K 0.43%
8,185
ICE icon
56
Intercontinental Exchange
ICE
$84.7B
$784K 0.42%
8,340
RGLD icon
57
Royal Gold
RGLD
$19.6B
$771K 0.42%
7,226
MRK icon
58
Merck
MRK
$322B
$759K 0.41%
8,329
+285
+4% +$25.3K
MAG
59
DELISTED
MAG Silver
MAG
$730K 0.39%
60,065
EQX icon
60
Equinox Gold
EQX
$13.5B
$685K 0.37%
154,395
PFE icon
61
Pfizer
PFE
$152B
$622K 0.34%
11,874
+505
+4% +$25.7K
NEM icon
62
Newmont
NEM
$123B
$611K 0.33%
10,245
+129
+1% +$9.13K
F icon
63
Ford
F
$56.2B
$586K 0.32%
52,725
-8,221
-13% -$113K
KDP icon
64
Keurig Dr Pepper
KDP
$39.5B
$518K 0.28%
14,665
VZ icon
65
Verizon
VZ
$196B
$516K 0.28%
10,176
+591
+6% +$29.9K
FISV
66
Fiserv Inc
FISV
$28.1B
$515K 0.28%
5,795
REGN icon
67
Regeneron Pharmaceuticals
REGN
$83.2B
$471K 0.25%
798
PRGO icon
68
Perrigo
PRGO
$1.75B
$414K 0.22%
+10,220
New +$380K
HD icon
69
Home Depot
HD
$354B
$399K 0.22%
1,455
+2
+0.1% +$590
VICI icon
70
VICI Properties
VICI
$28.8B
$392K 0.21%
13,163
+5,517
+72% +$163K
CCI icon
71
Crown Castle
CCI
$31.4B
$377K 0.2%
2,241
+131
+6% +$23.8K
TXN icon
72
Texas Instruments
TXN
$257B
$369K 0.2%
2,408
+169
+8% +$28.4K
AVGO icon
73
Broadcom
AVGO
$1.98T
$367K 0.2%
7,570
+490
+7% +$27.5K
PWR icon
74
Quanta Services
PWR
$101B
$365K 0.2%
2,918
BSX.PRA
75
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
$362K 0.2%
3,569

Similar funds

Chase Investment Counsel's Q2 2022 Portfolio in Review

As of Q2 2022, Chase Investment Counsel held 128 positions worth $185M, down 19% from $229M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Chase Investment Counsel withdrew a net $11.3M in Q2 2022, closing 29 positions and reducing 37 holdings. Its most notable exit was Concentrix, an estimated $4.16M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Chase Investment Counsel opened a new position in US Commodity Index worth $4.52M.

  • Chase Investment Counsel's largest Q2 2022 buy was US Commodity Index: 82,417 shares worth $4.52M.
  • Chase Investment Counsel added most to W.P. Carey in Q2 2022, an estimated $3.25M increase.
  • Chase Investment Counsel's biggest Q2 2022 reduction was Baker Hughes, cutting an estimated $2.12M.
  • Chase Investment Counsel fully exited Concentrix in Q2 2022, selling an estimated $4.16M.
  • Chase Investment Counsel's ten largest holdings make up 34% of its $185M portfolio in Q2 2022.
  • Chase Investment Counsel opened 16 new positions and closed 29 in Q2 2022.
  • Chase Investment Counsel's portfolio value fell 19% quarter-over-quarter to $185M.

Based on Chase Investment Counsel's 13F filing for Q2 2022, filed 26 Jul 2022.